InvestorWire NewsRoom


DGE’s 2nd REMS Virtual Summit to Draw Pharmaceutical and Life Science Professionals
September 14, 2021

DGE’s 2nd REMS Virtual Summit to Draw Pharmaceutical and Life Science Professionals

Date: October 11-12, 2021

Online Livestream

Dynamic Global Events (“DGE”) is proud to announce its 2nd Risk Evaluation and Mitigation Strategies (“REMS”) virtual summit. This two-day event, scheduled for October 11-12, 2021, will be an excellent avenue for life science professionals to develop decision making skills to adapt to anticipate FDA feedback with ease. This virtual conference is an exceptional resource for gaining new insights into adapting to risk mitigation strategies regarding submissions and modifications.

DGE has partnered with BioMed Wire, Pharma Voice, Pharma Marketing Networks, and FDA News Watch, among other enterprises, to offer a wholesome experience to event attendees. They have also customized the program to also appeal to technology vendors, drug safety service providers, pharmacovigilance or drug surveillance specialists, along with data management service providers.

This virtual summit will feature top industry experts from critical industry institutions, including Pfizer, Alexion, Merck, CVS, Amneal Pharmaceuticals, GlaxoSmithKline, and Walgreens. Some of the presenters include Kyle Irwin, Operations Lead REMs at Janssen, Jamie Wilkins, Director, Center of Excellence for Risk Management, Worldwide Safety at Pfizer and formerly of the FDA, Nancy Dubois, Associate Director, US Local Safety Officer at Alexion and more.

Participants will have an opportunity to interact with these industry leaders, exchange ideas and insights into REMS compliance along with how to communicate with healthcare professionals (“HCPs”), patients, and pharmacies.

With the involvement of key advisors within these industries, DGE has developed an agenda that covers all integral aspects of REMS core competencies.  Some of the challenges that will be addressed are how to monitor for risks of inadequate communications, maintaining compliance and inspection readiness, addressing new barriers facing retail pharmacy and specialty pharmacy, and techniques and technologies for effective REMS drug distribution. 

To learn more about the event, please visit our page

If interested in attending this virtual event visit

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).